Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 21

Trial Status

Completed3
Recruiting1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT05822609Phase 2Recruiting
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
Diabetic Kidney DiseaseType 1 Diabetes
PrincipalinvestigatorStart date: 2024-04-05
NCT03576716Phase 1Completed
Clearance of 25-hydroxyvitamin D3 During Vitamin D3 Supplementation
Chronic Kidney Disease
PrincipalinvestigatorStart date: 2018-06-01
NCT03104855Phase 1Completed
Clearance of 25-hydroxyvitamin D in Cystic Fibrosis
Cystic Fibrosis
PrincipalinvestigatorStart date: 2017-04-03
NCT02937350Phase 1Completed
Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease
Chronic Kidney Disease
PrincipalinvestigatorStart date: 2017-03-01

Research Network

Collaboration Network

25 collaborators·30 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jessica Kendrick, MD

University of Colorado Anschutz Medical Campus and Children's Hospital Colorado

Related
1 trials

Shared therapeutic areas:

Diabetic NephropathiesDiabetes Mellitus, Type 1

Worked with same sponsors:

Juvenile Diabetes Research FoundationProvidence Healthcare+3 more
Collaborated on 1 trial
Similarity Score24%

David Cherney, PhD, MD

University of Toronto

Related
1 trials

Shared therapeutic areas:

Diabetic NephropathiesDiabetes Mellitus, Type 1

Worked with same sponsors:

Juvenile Diabetes Research FoundationProvidence Healthcare+3 more
Collaborated on 1 trial
Similarity Score24%

Katherine Tuttle, MD

Providence Healthcare

Related
1 trials

Shared therapeutic areas:

Diabetic NephropathiesDiabetes Mellitus, Type 1

Worked with same sponsors:

Juvenile Diabetes Research FoundationProvidence Healthcare+3 more
Collaborated on 1 trial
Similarity Score24%

Irl Hirsch, MD

University of Washington

Related
4 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetic Nephropathies

Worked with same sponsors:

Juvenile Diabetes Research FoundationNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)+4 more
Collaborated on 1 trial
Similarity Score24%

Rémi Rabasa-Lhoret

Institut de Recherches Cliniques de Montreal

Related
16 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Cystic Fibrosis

Worked with same sponsors:

Juvenile Diabetes Research Foundation
Similarity Score15%

Suman Wason, MD

Lexicon Pharmaceuticals, Inc.

Related
23 trials

Shared therapeutic areas:

Chronic Kidney DiseasesDiabetes Mellitus, Type 1
Similarity Score15%

John F Tisdale, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
17 trials

Shared therapeutic areas:

Chronic Kidney Diseases
Similarity Score8%

Hamid Gourabi, PhD

head of Royan Institute

Related
52 trials

Shared therapeutic areas:

Chronic Kidney Diseases
Similarity Score8%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Chronic Kidney Diseases
Similarity Score8%

Toshimitsu Tokimoto

Astrazeneca KK

Related
16 trials

Shared therapeutic areas:

Chronic Kidney Diseases
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT05822609Phase 2PrincipalInvestigator

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

Diabetic Kidney DiseaseType 1 Diabetes
Recruiting
NCT03576716Phase 1PrincipalInvestigator

Clearance of 25-hydroxyvitamin D3 During Vitamin D3 Supplementation

Chronic Kidney Disease
Completed
NCT03104855Phase 1PrincipalInvestigator

Clearance of 25-hydroxyvitamin D in Cystic Fibrosis

Cystic Fibrosis
Completed
NCT02937350Phase 1PrincipalInvestigator

Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease

Chronic Kidney Disease
Completed

All 4 trials loaded